The online versions of legislation provided on this website are not official. Enrolled bills are the final version passed by the Ohio General Assembly and presented to the Governor for signature. The official version of acts signed by the Governor are available from the Secretary of State's Office in the Continental Plaza, 180 East Broad St., Columbus.
|
H. B. No. 463 As IntroducedAs Introduced
127th General Assembly | Regular Session | 2007-2008 |
| |
Cosponsors:
Representatives Beatty, Foley, Szollosi, Dodd, Skindell, Hughes, Otterman, J., Fende, Oelslager, Yuko, Brown, Luckie, Dyer, Chandler, Boyd, Sykes, Mallory, Williams, S., Strahorn
A BILL
To enact section 3701.265 of the Revised Code to
create the Triple Negative Breast Cancer
Commission.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:
Section 1. That section 3701.265 of the Revised Code be
enacted to read as follows:
Sec. 3701.265. (A) As used in this section, "triple negative
breast cancer" means the subtype of breast cancer characterized by
cells that lack receptors for the hormones estrogen and
progesterone and the protein receptor known as the human epidermal
growth factor receptor, or HER2, and therefore cannot be treated
with breast cancer drugs that target these receptors, including
such drugs as tamoxifen and trastuzumab.
(B) There is hereby created the triple negative breast cancer
commission for the following purposes:
(1) To gain a better understanding of why triple negative
breast cancer is more common among women who are African-American,
Hispanic, under forty years of age, and living in lower
socioeconomic conditions;
(2) To promote the study of triple negative breast cancer by
scientists and other researchers, physicians, and educators;
(3) To increase public awareness of triple negative breast
cancer.
(C) The director of health shall appoint the members of the
commission. The membership shall include individuals who are
familiar with triple negative breast cancer, including health care
professionals and individuals who have been personally affected by
the disease.
In making the appointments, the director shall specify the
length of each member's term. Members may be reappointed.
(D) The commission shall annually select from among its
members a chairperson. The commission shall meet at the call of
the chairperson, but not less than twice each year. A majority of
the members of the commission constitutes a quorum for the
transaction of business.
(E) Sections 101.82 to 101.87 of the Revised Code do not
apply to the commission.
|
|